Matthew David
2023
In 2023, Matthew David earned a total compensation of $1M as Chief Financial Officer at CorMedix, a 9% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $156,000 |
---|---|
Option Awards | $433,875 |
Salary | $389,135 |
Other | $52,140 |
Total | $1,031,150 |
David received $433.9K in option awards, accounting for 42% of the total pay in 2023.
David also received $156K in non-equity incentive plan, $389.1K in salary and $52.1K in other compensation.
Rankings
In 2023, Matthew David's compensation ranked 1,132nd out of 2,739 executives tracked by ExecPay. In other words, David earned more than 58.7% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,132 | 59th |
Manufacturing | 679 | 55th |
Chemicals And Allied Products | 453 | 46th |
Drugs | 442 | 45th |
Pharmaceutical Preparations | 301 | 48th |
David's colleagues
We found three more compensation records of executives who worked with Matthew David at CorMedix in 2023.